GGrantIndex
Sort

40,608 grants matching prostate cancer

N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia

$333,835
Paul Joseph Grippo · Northwestern University At Chicago · R01 · FY2012 · CA

p85/p110 PI3 Kinase-Structure, function and Physiology

$333,828
Jonathan M. Backer · Albert Einstein College Of Medicine · R01 · FY2013 · GM

Deciphering the function of the APE2 nuclease during repair by alternative end-joining and its role in HR-deficient cells

$333,766
Nausica C. Arnoult · University Of Colorado · R01 · FY2024 · CA

BEG4/MIM Function in Epithelial Neoplasia

$333,765
Anthony E Oro · Stanford University · R01 · FY2007 · AR

Arsenic, Histone Modification, and Transcription

$333,754
Lynn A Sheldon · Dartmouth College · R01 · FY2006 · ES

Targeted Death of Prostatic Cancer Cells

$333,750
Lankenau Institute For Medical Research · R01 · FY2003 · CA

Targeted Death of Prostatic Cancer Cells

$333,750
Lankenau Institute For Medical Research · R01 · FY2004 · CA

ROLE OF HOMEODOMAIN GENES IN HUMAN PROSTATE CANCER

$333,748
University Of Colorado Denver · R01 · FY2001 · CA

Hypoxia: Impact on Src Signaling and Prostate Cancer

$333,731
Dietmar W Siemann · University Of Florida · R01 · FY2019 · CA

Regulation of the tumor suppressor PTEN

$333,729
Tomas M Mustelin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2006 · CA

The Role of AKT in Prostate Cancer

$333,721
William R Sellers · Beth Israel Deaconess Medical Center · P01 · FY2010 · CA

MiRNAs/UCRs: biomarkers for cancer risk, tumor detection, progression & treatment

$333,718
Carlo M Croce · Ohio State University · U01 · FY2013 · CA

Determinants of AGR2 effects in Barrett's esophagus and esophageal adenocarcinoma

$333,690
Anson W Lowe · Stanford University · R01 · FY2010 · DK

Use of Regression Models in Cost-effectiveness Analysis

$333,674
Joseph C Gardiner · Michigan State University · R01 · FY2006 · HS

LOCALIZATION OF SUSCEPTIBILITY LOCI IN PROSTATE CANCER

$333,648
Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · CA

Prostate Cancer Prevention by Procyanidins in Grape Seed Extract

$333,644
Chapla Agarwal · University Of Colorado Denver · R01 · FY2009 · CA

Management of Breathing effects in Radiotherapy Planning

$333,640
Thomas R. Bortfeld · Massachusetts General Hospital · R01 · FY2007 · CA

Nautral products for targeting Skp2 in cancer interception

$333,625
Xiaolin Zi · University Of California-Irvine · UG3 · FY2025 · CA

Nautral products for targeting Skp2 in cancer interception

$333,625
Xiaolin Zi · University Of California-Irvine · UG3 · FY2024 · CA

Core-Biomarker Reference Laboratory

$333,610
Oliver John Semmes · Old Dominion University · U2C · FY2024 · CA

Enzymology of H2S Biogenesis

$333,601
Ruma V Banerjee · University Of Michigan At Ann Arbor · R01 · FY2013 · HL

Chemokines, TRP Channels and Cancer Pain

$333,594
Durga Prasanna Mohapatra · Washington University · R01 · FY2015 · NS

CYP17A1-independent androgen synthesis and prostate cancer resistance to next-generation hormonal therapy

$333,575
Nima Sharifi · University Of Miami School Of Medicine · R01 · FY2024 · CA

Leveraging PMN immune response to overcome ADT resistance in bone metastatic prostate cancer

$333,575
Grinu Mathew · University Of Nebraska Medical Center · R01 · FY2024 · CA

Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression

$333,575
Priyamvada Rai · University Of Miami School Of Medicine · R01 · FY2024 · CA